Mechanisms underlying atrial fibrillation in chronic kidney disease

Area of Science:

• Nephrology
• Cardiology
• Pathophysiology

Background:

• Chronic kidney disease (CKD) affects 15% of the global population and is linked to increased mortality, primarily from cardiovascular disease.
• Cardiovascular complications in CKD patients include left ventricular hypertrophy, heart failure, and cardiac arrhythmias, with atrial fibrillation (AF) being the most common.
• The higher incidence of AF in CKD patients underscores the need to understand the mechanisms driving CKD-induced AF.

Purpose of the Study:

• To review the systemic factors linking CKD to AF pathogenesis.
• To highlight the role of inflammatory mediators in CKD-induced atrial arrhythmogenesis.
• To discuss experimental models and management strategies for AF in CKD patients.

Main Methods:

• Literature review of systemic factors connecting CKD and AF.
• Analysis of inflammatory mediators involved in CKD-induced atrial arrhythmogenesis.
• Discussion of experimental models and clinical management considerations.

Main Results:

• CKD is associated with increased risk of AF through various systemic factors.
• Inflammatory mediators play a significant role in the development of AF in CKD.
• Special considerations are needed for experimental models and clinical management of AF in CKD patients.

Conclusions:

• A deeper understanding of the molecular mechanisms underlying the CKD-AF connection is crucial.
• High-quality clinical investigations are necessary to further elucidate the relationship between CKD and AF.
• Improved understanding will aid in better management and treatment strategies for CKD patients with AF.